Oslo, Norway—A discrepancy over patents is continuing in the krill market segment. On October 2, Aker BioMarine asked the U.S. Trademarks and Patents Office (USTPO) to consider some additional evidence regarding the legitimacy of patent (U.S. Pat. No 8,278,351, i.e., the “’351 Patent”) assigned to Neptune Technologies & Bioressources Inc. of Laval, Quebec, Canada.
Chester, NJ—A recent clinical trial published in Phytotherapy Research indicated that a high-absorption curcumin (BCM-95 from Dolcas Biotech, based here) had similar effects as a generic form of Prozac (fluoxetine) on depression, sans the adverse effects.
Benicia, CA—Two published studies on a branded ingredient show much promise for overweight individuals. The herbal formulation studied combines Sphaeranthus indicus and Garcinia mangostana (Meratrim, from InterHealth Nutraceuticals, based here).